Vermillion (NASDAQ:VRML) has changed its name to Aspira Women’s Health (NYSE:AWH), effective today and will trade on the Nasdaq Stock Market under the new
Vermillion, Inc. (NASDAQ: VRML) shares were trading higher on Wednesday, after the company announced it completed validation of new pre-surgical test offerings with OVA1 plus,...
Vermillion (NASDAQ:VRML) subsidiary ASPIRA Labs has finished validating Roche's Elecsys Anti-SARS-CoV-2 antibody blood test in addition to several new onco
U.S. Stock Indices Post Worst Performance of Year As Global Economic Worries Sour SentimentU.S. stocks ended sharply lower Tuesday as concerns over a Greek debt default and China's...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Strong Sell||Strong Sell||Strong Sell||Neutral||Buy|
|Technical Indicators||Sell||Strong Sell||Strong Sell||Strong Sell||Strong Buy|
|Summary||Strong Sell||Strong Sell||Strong Sell||Sell||Strong Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Belt Hold Bullish||15||Current|
|Falling Three Methods||1D||1||Jul 07, 2020|
|Doji Star Bearish||1H||2||Jul 08, 2020 01:00PM|
|Doji Star Bearish||1M||4||Mar 20|
Aspira Women’s Health Inc., formerly Vermillion, Inc., is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. The Company sells OVA1, Overa and OVA1PLUS risk of malignancy tests for ovarian cancer. The Company also sells a product for genetic testing for specific women’s health diseases, called ASPiRA GenetiX, with a core focus on ovarian cancer. OVA1 is a blood test designed to, in addition to a physician’s clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor before planned surgery. The Overa is a second-generation biomarker panel intended to maintain its product’s sensitivity while improving specificity. OVA1PLUS is a service offering combining its OVA1 and Overa products, designed to enhance accuracy and reduce false elevations in the intermediate-risk area.Read More
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's xhaszzx.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.